Veradace Capital Management’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CYRX
CCM
FAM
MCO
Veradace Capital Management's CYRX Position: Q2 2026 in Review
Veradace Capital Management increased its CryoPort (CYRX) stake by 372% in Q2 2026, buying an estimated $1.35M and bringing the position to 133,607 shares worth $2.1M. The position accounts for 1.58% of the portfolio, ranked #13.
Veradace Capital Management first reported a position in CYRX in Q1 2026 and has held it in 2 quarters since. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.
- Veradace Capital Management held 133,607 shares of CryoPort worth $2.1M as of Q2 2026.
- Veradace Capital Management bought 105,274 CryoPort shares in Q2 2026, an estimated $1.35M.
- CryoPort made up 1.58% of Veradace Capital Management's portfolio in Q2 2026, its #13 holding.
- Veradace Capital Management first reported a position in CryoPort in Q1 2026 and has held it in 2 quarters since.
- 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.
Based on Veradace Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.